Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supha Pharmachem Ltd has informed BSE that the trading window for dealing in the company's securities will be closed for insiders starting January 1, 2026. The window will remain shut until 48 hours after the company declares its Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ending December 31, 2025. The date of the board meeting to consider these Q3 results will be announced separately. This is a routine compliance filing under SEBI's Insider Trading Regulations, 2015.
This is a standard regulatory filing and does not directly impact shareholders. It signals that Q3 FY26 results are forthcoming and insiders (directors, employees, etc.) are barred from trading until results are publicly disclosed.